Concurrent Sessions C01 - C07 - Sunday, June 9 - 13.15 - 14.45 hrs
Room | Tokyo | Sydney | Hall 7a | Hall 7b | St. Petersburg | Seoul |
C01. New Genes and New Therapies in Clinical Genetics | C02. Basic Research in Cancer Genetics | C03. Skeletal Disorders: From Gene to Function | C04. Cytogenetics | C05. Dissecting Complex Traits | C06. Genome Evolution and Variation | |
13.15 | C01.1 Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. D. A. Koolen, J. M. Kramer, K. Neveling, W. M. Nillesen, H. L. Moore-Barton, F. V. Elmslie, A. Toutain, J. Amiel, V. Malan, A. Chun-Hui Tsai, S. W. Cheung, C. Gilissen, E. T. P. Verwiel, T. Feuth, E. M. H. F. Bongers, H. Scheffer, L. E. L. M. Vissers, A. P. M. de Brouwer, H. G. Brunner, J. A. Veltman, A. Schenck, H. G. Yntema, B. B. A. de Vries | C02.1 KIAA1797/FOCAD encodes a novel focal adhesion protein with tumor suppressor function in gliomas A. Brockschmidt, D. Trost, H. Peterziel, K. Zimmermann, M. Ehrler, H. Grassmann, P. Pfenning, A. Waha, D. Wohlleber, F. F. Brockschmidt, M. Jugold, A. Hoischen, C. Kalla, A. Waha, G. Seifert, P. A. Knolle, E. Latz, V. H. Hans, W. Wick, A. Pfeifer, P. Angel, R. G. Weber | C03.1 Arm to Leg Transformation in Humans associated with CNVs at the PITX1 locus M. Spielmann, E. Klopocki, F. Brancati, P. Krawitz, J. Hecht, D. Ibrahim, K. Dathe, P. Ferrari, S. Lohan, U. Mennen, S. Mundlos | C04.1 High frequency of indels at the breakpoint junctions of MECP2 duplication rearrangements strongly support replicative-based mechanisms C. M. B. Carvalho, M. B. Ramocki, D. Pehlivan, S. Cheung, L. M. Franco, J. W. Belmont, H. Y. Zoghbi, P. J. Hastings, J. R. Lupski | C05.1 RNAi-based functional profiling of loci from blood lipid genome-wide association studies H. Runz, P. Blattmann, C. Schuberth, R. Pepperkok | C06.1 The evolution of African great ape subtelomeric heterochromatin and the fusion of human chromosome 2 C. R. Catacchio, M. Ventura, S. Sajjadian, L. Vives, P. H. Sudmant, T. Marques-Bonet, T. A. Graves, R. K. Wilson, E. E. Eichler |
13.30 | C01.2 Mutations in the KIAA1267 gene cause the 17q21.31 deletion syndrome phenotype. M. Zollino, D. Orteschi, M. Murdolo, S. Lattante, P. Chiurazzi, G. Marangi, G. Neri | C02.2 Exome sequencing of late recurrence T-cell acute lymphoblastic leukemia in children confirms second leukemia and exposes predisposition candidate genes E. Waanders, V. H. J. Van der Velden, T. SzczepaÅ„ski, L. E. L. M. Vissers, J. de Ligt, C. Gilissen, A. H. A. van Dijk, S. V. Van Reijmersdal, P. M. Hoogerbrugge, A. Geurts van Kessel, J. J. M. Van Dongen, R. P. Kuiper | C03.2 Microduplications Upstream of MSX2 are Associated with a Phenocopy of Cleidocranial Dysplasia C. E. Ott, H. Hein, S. Lohan, A. M. Hoogeboom, N. Foulds, J. Grünhagen, S. Stricker, P. Villavicencio-Lorini, E. Klopocki, S. Mundlos | C04.2 How to deal with genomic imbalances in the imprinted region 11p15.5: Insights in the complex regulation of two imprinting domains T. Eggermann, M. Begemann, M. Gogiel, A. Dufke, I. Spier, I. Spier, S. Spengler | C05.2 Accumulation of common genetic variants influences lipid levels in patients with T2D and improves prediction of hypercholesterolemia S. M. Willems, A. Hofman, B. A. Oostra, C. M. van Duijn, A. Isaacs; | C06.2 Genome-wide search for gender different genetic loci for human anthropometric traits: Methods and results from genome-wide meta-analyses across 270,000 Individuals T. W. Winkler, J. C. Randall, Z. Kutalik, S. I. Berndt, R. J. F. Loos, C. M. Lindgren, K. E. North, I. M. Heid |
13.45 | C01.3 Loss of function mutations in TGFB2 cause Loeys-Dietz syndrome D. Schepers, M. E. Lindsay, N. Ajit Bolar, J. Doyle, E. Gallo, J. Fert-Bober, M. J. E. Kempers, E. K. Fishman, Y. Chen, L. Myers, D. Bjeda, G. Oswald, B. Anderlid, M. H. Yang, E. M. H. F. Bongers, J. Timmermans, A. C. Braverman, N. Canham, G. R. Mortier, H. G. Brunner, P. H. Byers, J. Van Eyck, L. Van Laer, H. C. Dietz, B. L. Loeys | C02.3 Somatic GATA2 zinc finger 1 mutations are exclusively associated with bi-allelic CEBPA mutations in acute myeloid leukemia (AML) and disrupt the capacity of GATA2 to enhance CEBPA-mediated activation of transcription P. A. Greif, A. Dufour, N. Konstandin, B. Ksienzyk, E. Zellmeier, B. Tizazu, J. Sturm, T. Benthaus, M. Yaghmaie, P. Dörge, K. Hopfner, A. Hauser, A. Graf, S. Krebs, H. Blum, P. M. Kakadia, S. Schneider, E. Hoster, F. Schneider, M. Stanulla, J. Braess, M. C. Sauerland, W. E. Berdel, T. Büchner, B. J. Woermann, W. Hiddemann, K. Spiekermann, S. K. Bohlander | C03.3 Mutations in distinct domains of BMP1 cause Osteogenesis Imperfecta with variable bone phenotypes K. Keupp, A. Nair, O. Semler, Y. Li, H. Thiele, P. Frommolt, J. Becker, C. Netzer, N. Arkasu, E. Schoenau, P. Nürnberg, M. Hammerschmidt, T. Carney, B. Wollnik | C04.3 Nonlinear and nonrandom genome organization of SNRPN, UBE3A, and GABRB3 in the normal human nucleus by three-color 3D-fluorescence in situ hybridization R. Kawamura, H. Tanabe, T. Wada, S. Saitoh, Y. Fukushima, K. Wakui | C05.3 Detailed metabolic and genetic characterization of known lipid loci T. Tukiainen, J. Kettunen, A. J. Kangas, L. Lyytikäinen, P. Soininen, A. Sarin, E. Tikkanen, P. F. O'Reilly, M. J. Savolainen, K. Kaski, A. Pouta, A. Jula, T. Lehtimäki, M. Kähönen, J. Viikari, M. Taskinen, M. Jauhiainen, J. G. Eriksson, O. Raitakari, V. Salomaa, M. Järvelin, M. Perola, A. Palotie, M. Ala-Korpela, S. Ripatti | C06.3 Analysis of structural variation in the Genome of the Netherlands (GoNL) project V. Guryev, W. Kloosterman, L. Francioli, J. Y. Hehir-Kwa, E. Lameijer, A. Abdellaoui, J. de Ligt, V. Koval, N. Amin, F. van Dijk, L. C. Karssen, H. Mei, K. Ye |
14.00 | C01.4 Identification of the cause of Blue Rubber Bleb Nevus Syndrome J. Soblet, N. Limaye, M. Cordisco, A. Dompmartin, O. Enjolras, S. Holden, A. D. Irvine, C. Labrèze, A. Lanoel, P. N. Rieu, S. Syed, C. J. van der Vleuten, R. Watson, S. J. Fishman, J. B. Mulliken, L. M. Boon, M. Vikkula | C02.4 Integrated genomic and epigenomic profiling of TP53 and non-TP53 Li-Fraumeni syndrome (LFS) tumors reveals multiple and shared hits in the p53 network R. Krahe, B. Zhang, X. Hu, J. W. Wong, C. D. Wilson, K. A. Baggerly, N. E. Navin, L. C. Strong, L. L. Bachinski | C03.4 Increased sensitivity to DNA damage in a recessive form of Weaver syndrome caused by functional loss of an E3 ubiquitin ligase G. Yigit, F. Percin, Y. Li, N. Bögershausen, L. Basel-Vanagaite, H. Kayserili, Y. Alanay, K. E. Brown, E. Milz, R. Wirth, P. Prontera, A. Küchler, V. Cormier-Daire, D. Wieczorek, B. Wollnik | C04.4 Age-related somatic structural changes in the nuclear genome of human blood cells L. A. Forsberg, C. Rasi, H. R. Razzaghian, G. Pakalapati, L. Waite, K. S. Thilbeault, A. Ronowicz, N. E. Wineinger, H. K. Tiwari, D. Boomsma, M. P. Westerman, J. R. Harris, R. Lyle, M. Essand, F. Eriksson, T. L. Assimes, C. Iribarren, E. Strachan, T. P. O'Hanlon, L. G. Rider, F. W. Miller, V. Giedraitis, L. Lannfelt, M. Ingelsson, A. Piotrowski, N. L. Pedersen, D. Absher, J. P. Dumanski | C05.4 Estimating the fraction of established metabolic trait loci with discernible pleiotropic effects L. Marullo, B. K. Cornes, J. Dupuis, J. B. Meigs, A. Morris, I. Prokopenko | C06.4 Duplications at PAK7 are a significant risk factor for schizophrenia and bipolar disorder D. W. Morris, P. Cormican, R. D. Pearson, B. P. Riley, C. C. Spencer, E. M. Kenny, B. S. Maher, B. Wormley, G. Donohoe, D. Tropea, B. P. Coe, E. E. Eichler, A. McQuillin, H. Gurling, D. Blackwood, F. A. O'Neill, S. GENE+ Consortium, I. nternational Schizophrenia Consortium, W. T. C. C. C, W. T. C. C. C2, K. S. Kendler, M. Gill, P. Donnelly, A. P. Corvin |
14.15 | C01.5 Serin diet relieves symptoms of Hereditary Sensory and Autonomous Neuropathy type 1A caused by a c.992 C>T, p.(Ser331Phe), mutation in SPTLC1 B. W. Rautenstrauss, E. Wilichowski, E. Holinski-Feder, T. Hornemann; | C02. 5Leupaxin mediates cytoskeleton remodeling in prostate cancer cells S. Dierks, S. von Hardenberg, T. Schmidt, P. Burfeind, S. Kaulfuß; | C03.5 Mutations at a single codon in Mad Homology 2 domain of SMAD4 cause Myhre syndrome C. Le Goff, C. Mahaut, A. Abhyankar, W. le Goff, V. Serre, A. Afenjar, A. Brooks, N. Brunetti-Pieri, P. Campeau, A. Destrée, M. di Rocco, R. Hennekam, D. Héron, S. Jacquemont, S. Mansour, S. Marlin, R. McGowan, H. Murphy, M. Simon, I. Stolte- Dijkstra, J. Tolmie, N. Van der Aa, T. van Essen, A. Verloes, J. Casanova, A. Munnich, V. Cormier-Daire | C04.5 Clinically relevant mosaic findings in a total of 8,374 patients and parents in constitutional genome diagnostics using genome wide high resolution SNP array analysis N. de Leeuw, J. Y. Hehir-Kwa, B. H. W. Faas, T. K. Rinne, M. J. E. Kempers, S. A. de Munnik, N. F. A. Leijsten, T. C. Machielsen, S. L. J. van Gessel, M. Wunderink, M. J. G. Banning, R. van Beek, M. del Rosario, B. B. A. de Vries, D. F. C. M. Smeets, R. Pfundt; | C05.5 Dysfunctional NO signaling due to a double mutation in GUCY1A3 and CCT7 identified by whole exome sequencing increases risk for myocardial infarction J. Erdmann, K. Stark, U. Esslinger, F. Kaiser, C. CARDIoGRAM, H. Schunkert, C. Hengstenberg; | C06.5 Variation in transcription factor binding among humans M. Kasowski, F. Grubert, C. Heffelfinger, M. Hariharan, A. Asabere, S. Waszak, L. Habegger, J. Rozowsky, M. Shi, A. Urban, M. Hong, K. Karczewski, W. Huber, S. Weissman, M. Gerstein, J. Korbel, M. Snyder; |
14.30 | C01.6 SMA patients show concordant responses to valproic acid from blood to neurons while nonresponsivness is facilitated by CD36 L. Garbes, L. Hessen, J. Schreml, I. Hoelker, T. Bauer, C. Mueller, J. Dimos, M. Peitz, O. Bruestle, R. Heller, B. Wirth | C02.6 Clinical Application of Next Generation Sequencing Technology for the Detection of Clinically Actionable Mutations Y. Wen, E. Fang, Y. Li, G. Douglas, C. E. Carmack, M. M. Li | C03.6 Homozygossity mapping and whole exome sequencing identifies MAP4 mutations in short stature C. T. Thiel, D. Zahnleiter, U. Trautmann, A. B. Ekici, A. Reis, H. Doerr, A. Rauch | C04.6 Modelling neurogenesis impairment in Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 Y. Hibaoui, I. Grad, M. R. Sailani, A. Letourneau, S. Dahoun, S. Gimelli, M. F. Pelte, F. Béna, S. E. Antonarakis, A. Feki | C05.6 Gene expression in an extended pedigree S. B. Montgomery, X. Li, K. Karczewski, K. Smith | C06.6 Poly(A) binding protein nuclear 1 (PABPN1) levels affect alternative polyadenylation E. de Klerk, A. Venema, Y. S. Anvar, J. J. Goeman, J. T. den Dunnen, S. M. van der Maarel, V. Raz, P. A. C. 't Hoen |